AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06615882 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: stent-angioplasty & nimodipine infusion (During the stent (Solitaire-X) -angioplasty, IA nimodipine was also infused)
Description: I. Procedure \& Intervention~1. Assess the presence and degree of cerebral vasospasm of the target vessel through cerebral angiography before the procedure.~2. Solitaire-X stent types are selected~3. During the stent-angioplasty, IA nimodipine was also infused.~4. Retrieve Solitaire-X after maintaining deployment for 3 minutes.~5. Additional procedures are determined through immediate post-procedure and 15-minute delayed cerebral angiography.
Study NCT06616012 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neosense umbilical catheter
Description: The Neosense umbilical catheter is used instead of a standard umbilical catheter
Study NCT06616350 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: esTOCma: an app to fight stigma associated with OCD
Description: The intervention consists of playing a serious game, called esTOCma, on a mobile phone. In the game, players must use their knowledge to battle the stigma monster of OCD, complete 10 missions, and release 10 individuals who have been afflicted by the esTOCma monster, a creature that feeds on false beliefs and misinformation in society.
Study NCT03432065 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buspirone
Description: Children with autism spectrum disorders will receive buspirone treatment for eight weeks. Buspirone will be titrated to the maximum daily dose during the first four weeks of the trial (dose titration phase). Week 4 onwards, subjects will be maintained on maximum achieved dose until the end of the trial. During the titration phase, total dose will be increased by 10mg at each visit and by 5mg on the 4th day after each visit.
Study NCT06502587 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood flow restriction training
Description: we will apply blood flow restriction training with low intensity exercises like knee flexion ,knee extension and straight leg raise 10 repetitions 2 sets a day and 3 times/week a rest interval of 2 minutes between exercises, for 30 minutes of this whole procedure.~total 12 sessions given in 4 weeks each session of maximum 30 minutes
Study NCT06502587 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound therapy
Description: All subjects will be given Ultrasound therapy as per patient requirement with 1.5 Watts/cm\^2 in continuous mode around knee joint. Conservative exercises(quads isometric exercise, pillow squeeze, heel raise, straight leg raise and side leg raise) will be applied for 3 times per week (daily one set of 10 repetitions) They will be given this treatment for 3 times per week
Study NCT05284812 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
Description: Subjects receive low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02) injection into the deltoid muscle of the upper arm
Study NCT05284812 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
Description: Subjects receive low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02) injection into the deltoid muscle of the upper arm
Study NCT05284812 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: High-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
Description: Subjects receive high-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02) injection into the deltoid muscle of the upper arm
Study NCT05284812 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: High-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
Description: Subjects receive high-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02) injection into the deltoid muscle of the upper arm
Study NCT05284812 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: High-dose adjuvant for freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
Description: Subjects receive high-dose adjuvant for freeze-dried recombinant tuberculosis vaccine (AEC / BC02) injection into the deltoid muscle of the upper arm
Study NCT05284812 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lyophilized recombinant tuberculosis vaccine (AEC / BC02) placebo
Description: Subjects receive Lyophilized recombinant tuberculosis vaccine (AEC / BC02) placebo injection into the deltoid muscle of the upper arm
Study NCT05284812 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Lyophilized recombinant tuberculosis vaccine (AEC / BC02) placebo
Description: Subjects receive Lyophilized recombinant tuberculosis vaccine (AEC / BC02) placebo injection into the deltoid muscle of the upper arm
Study NCT06390943 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Facility-based feeding support package plus (FB-FSP+)
Description: Package of materials to support facility-based feeding and lactation, KMC and WASH, including a training curriculum, training guide, and implementation materials, such as Standard Operating Procedures (SOPs) and job aides
Study NCT06390943 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Transition-to-home feeding support package plus (TTH-FSP+)
Description: Package of materials to support transition-to-home feeding and lactation, KMC and WASH, including a training curriculum, training guide, and implementation materials, such as Standard Operating Procedures (SOPs) and job aides
Study NCT05263115 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Resistance Exercise intervention
Description: 12-week progressive resistance exercise intervention
Study NCT05263115 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional stair climbing and stepping-based exercise intervention
Description: 12-week progressive stair climbing and stepping-based exercise intervention
Study NCT06318104 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tegoprazan
Description: Tegoprazan 50 mg BID + amoxicillin 1 gr BID + clarithromycin 500 mg BID all for 14 days.
Study NCT06318104 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole 40mg
Description: Esomeprazole 40 mg BID + amoxicillin 1 gr BID + clarithromycin 500 mg BID all for 14 days.
Study NCT06259474 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Hypopressive Exercises and (heat therapy, medication, and progressive strength training)
Description: 20 subjects combined HE with traditional treatments for LBP (heat therapy, medication, and progressive strength training). Each session consisted of 5 to 10 HEs. Participants were instructed not to hold their breath or perform PFMS contractions during the HEs. Traditional treatment for low back pain typically involved using medications like acetaminophen (0.5-1 g three times daily) and heat therapy, which consisted of using a continuous heat wrap for 2 hours, 3 times per week at 40 °C, one hour before and after the session
Study NCT06259474 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Hypopressive Exercises and (heat therapy, medication, and progressive strength training)
Description: 20 subjects combined HE with traditional treatments for LBP (heat therapy, medication, and progressive strength training). Each session consisted of 5 to 10 HEs. Participants were instructed not to hold their breath or perform PFMS contractions during the HEs. Traditional treatment for low back pain typically involved using medications like acetaminophen (0.5-1 g three times daily) and heat therapy, which consisted of using a continuous heat wrap for 2 hours, 3 times per week at 40 °C, one hour before and after the session
Study NCT05172388 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Air purifier
Description: Real purification and sham purification would be conducted in the dormintory rooms (about 25 in total) of the study subjects for 4 days, following a randomized crossover design, which means a real air purifier and a sham purifier would be placed in the same dormintory room with a wash-out interval (15 days).
Study NCT05172388 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Air purifier
Description: Real purification and sham purification would be conducted in the dormintory rooms (about 25 in total) of the study subjects for 4 days, following a randomized crossover design, which means a real air purifier and a sham purifier would be placed in the same dormintory room with a wash-out interval (15 days).
Study NCT04878198 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Jogging program
Description: This intervention consists of 50 sessions of morning jogging sessions at moderate intensity level. Each intervention session will be administered by a trained research assistant assisted by student helpers. All the research staff (i.e. student helpers and research assistant) will be required to attend a workshop (see educational plan) to standardize the procedure on implementing the intervention, as well as handling and motivating their ASD partners. Motivation techniques in previous protocol will be used to enhance the compliance rate.
Study NCT04878198 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin supplement intervention
Description: This intervention is a 10-week melatonin supplement intervention where melatonin supplement will be provided 30 minutes before bedtime.
Study NCT05124847 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Care
Description: Participants will receive nutritional education sessions and will be instructed to maintain an intake window of at least 13 hours a day, preferably every day of the week and in any case at least 6 days a week.
Study NCT05124847 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time restricted eating
Description: A personalized progression will be established to progressively reduce the intake window during the first 10 days of intervention. After these first 10 days, the participants will be prescribed to limit food intake to a maximum of 10 hours a day, at least 5 days a week. Participant can freely select the time of day to place the intake window. However, it will be recommended to avoid making the last intake in the 3 hours before going to bed. After 4 weeks of intervention, the dietitian will invite them to reduce the intake window to 9 or 8 hours, if they consider it feasible, maintaining this new intake window during the last 4 weeks of intervention. The intake window can be maintained at 10 hours until the end of the study.
Study NCT06130852 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Parent Training
Description: 10 thematic sessions aimed at changing the parent's view of their child by encouraging them to focus on appropriate behaviors. The sessions focus on specific themes such as positive attention, the principle of reinforcement, or even homework management.
Study NCT05380934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQH3821 tablets
Description: TQH3821 tablets is an Interleukin-1 receptor-associated kinase 4 inhibitor that exhibits a high degree of inhibitory activity against IRAK4 kinase.
Study NCT05380934 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TQH3821 tablets (Placebo)
Description: TQH3821 tablets (Placebo) is a placebo produced with reference to TQH3821 tablets, which has no effect on IRAK4 kinase.
Study NCT05380934 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Methotrexate tablets
Description: Methotrexate tablets is a folic acid antagonist, which belongs to an anti-rheumatic drug to improve the condition
Study NCT05380934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate tablets
Description: Methotrexate tablets is a folic acid antagonist, which belongs to an anti-rheumatic drug to improve the condition
Study NCT05899387 — intervention group
Intervention type: PROCEDURE
Intervention: Swap collection
Description: Performing the surgery (Mastectomy with or without implant reconstruction; Insertion of Breast implants for control group 3) according to valid standards.~In addition, taking swabs intraoperatively according to protocol from skin and surgical site.
Study NCT05899387 — intervention group
Intervention type: PROCEDURE
Intervention: Seroma punction
Description: Puncturing of a seroma in case of occurence and clinical need
Study NCT06449560 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Practice Group
Description: Participants in this group engage in the traditional core course (1-hour lecture on upper limb soft tissue differential diagnosis and assessment techniques. They have the opportunity to observe teacher demonstrations, and the course content and instructional demonstrations are consistent and delivered by the same therapist), followed by a 20-minute practical session where they pair up for mutual hands-on practice. The assessment of upper limb soft tissue operations takes approximately 4 minutes per session, allowing for approximately 5 practice sessions.
Study NCT06449560 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Practice Group
Description: Participants in this group engage in the traditional core course (1-hour lecture on upper limb soft tissue differential diagnosis and assessment techniques. They have the opportunity to observe teacher demonstrations, and the course content and instructional demonstrations are consistent and delivered by the same therapist), followed by a 20-minute practical session where they pair up for mutual hands-on practice. The assessment of upper limb soft tissue operations takes approximately 4 minutes per session, allowing for approximately 5 practice sessions.
Study NCT06449560 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video Feedback Group
Description: Participants receive the traditional core course (as the same in the practice group) along with a 20-minute video feedback session. Initially, a therapist records students' assessment techniques in action, capturing the dynamic process on video. The recorded video is then played on a screen for both the course teacher and students to watch together. Participants can annotate specific actions during the viewing, and the course teacher facilitates a reflective discussion where participants observe and identify any issues or correct actions as expected. The teacher provides feedback on areas of improvement in the action process for further practice. The self-viewing of the recorded video serves as a valuable tool for enhancing the skill performance of physical therapy interns.
Study NCT05657158 — intervention group
Intervention type: OTHER
Intervention: Brolucizumab
Description: Participants with cases of RV and/or RO reported to Novartis Patient Safety following brolucizumab use in routine clinical practice for which images were provided to Novartis and read by the Reading Centre were included
Study NCT04637529 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S (+) - Ibuprofen
Description: S (+) - Ibuprofen + placebo of Ibuvix®
Study NCT05882942 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Matcha green tea
Description: This is the condition with the Matcha green tea
Study NCT05882942 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: This is the condition with the placebo
Study NCT04637529 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuvix® - ibuprofen
Description: Ibuvix® + placebo of S(+) - Ibuprofen
Study NCT05448456 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid
Description: 1 gram of tranexamic acid in 100 ml of 0.9% normal saline
Study NCT05448456 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 100 ml of 0.9% normal saline
Study NCT06101173 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio)
Description: 1 dose of VLP-Polio vaccine (0.5ml) on Visit 1
Study NCT06101173 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Inactivated poliomyelitis vaccine (IPOL)
Description: 1 dose of IPOL vaccine (0.5ml) on Visit 1
Study NCT06101173 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VLP-Polio
Description: 1 dose of VLP-Polio vaccine (0.5ml) on Visit 1
Study NCT06101173 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: IPOL
Description: 1 dose of IPOL vaccine (0.5ml) on Visit 1
Study NCT06488079 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Summary Label
Description: The Nutri-Score Front-of-Pack nutritional label
Study NCT05320978 — intervention group
Intervention type: DEVICE
Intervention: Hand grip test, computed tomography
Description: A hand grip test, abdominal computed tomography are performed before surgery.
Study NCT06284759 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: post-discharge telenursing intervention
Description: Tele-nursing based on Orem's Self-Care Theory was applied to patients with lower extremity fracture surgery. Phone/video calls 24-48 after discharge. hours, 7-10. day,18-21. day, 28-30th day and 40-45th day. day was made. Telephone or video conference interviews were held on the day and time convenient for the patient. After each meeting, the date and time of the next meeting was planned. The video conferencing method (zoom, skype, whatsapp, etc.) was presented to the patient's preference and the decision was made together. In phone/video conference calls, patients were informed about their current problems. Additionally, patients' questions were answered. Prior to tele-nursing monitoring, the researchers identified emergent or urgent situations; Patients were informed that they should consult their doctor if this occurs. The interview with each patient lasted an average of 30 minutes.
Study NCT04923061 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupressure
Description: In the acupressure group, heart meridian 7th point (HT7), large intestine meridian 4th point, stomach meridian 36th point (ST36) and spleen meridian 6th point (SP6) will be applied. Tissue sensitivity will be reduced by heating and rubbing for about 20 seconds without direct pressure on the acupressure points, and the points will be ready for acupressure application. Subsequently, consecutive (breathing rhythm) compressions will be applied to the acupressure points determined by the researcher, without raising the finger, taking into account the pain threshold of the individual who is applied with the thumb, with 10 seconds of pressure for two seconds of relief Since the symmetry of the selected four different points will also be applied to the other extremity, a total of 16 minutes of compression will be applied to each point, provided that it is two minutes. Each nurse's session will be approximately 20 minutes, depending on the preparation and compression time on each point.
Study NCT04923061 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham acupressure group
Description: In the sham group, acupressure will be applied on the bone region where the meridians do not pass, approximately 1-1.5 cm away from the HT7, LI4, ST36, SP6 points. The application process will continue in the same way with acupressure group and the pressure intensity will be less.
Study NCT06488079 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutrient-specific label
Description: The NutrInform Battery Front-of-Pack nutritional label
Study NCT06488079 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: No label
Description: Conventional food educational flyer
Study NCT05544643 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtronic Extended Mio 30 Infusion Set
Description: Safety and Efficacy of Medtronic Extended Mio 30 Infusion Set
Study NCT06214754 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PCI
Description: The subjects underwent immediate coronary angiography after Percutaneous transluminal coronary angioplasty to evaluate the success rate of instruments, and immediate coronary angiography after PCI to evaluate the success rate of clinical treatment
Study NCT05899387 — intervention group
Intervention type: PROCEDURE
Intervention: Blood sampling
Description: Blood sampling at defined time points according to protocol
Study NCT06066203 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GNC-035
Description: GNC-035 was administered by intravenous infusion for 2 h-4 h, once a week ( IV, QW ), 3 weeks as a cycle.
Study NCT05989490 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Static stretching
Description: The participants are assigned to four bouts of static stretching of the right knee flexors with a 20-second rest period between bouts 20 to the point of discomfort and to the point of pain.
Study NCT06290947 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BFR Cuffs for Intervention Group
Description: The intervention consists of supervised treadmill sessions incorporating specialized BFR cuffs, branded as H+ Curve, tailored for Blood-Flow Restriction Walk Training (BFRw). These cuffs are strategically positioned on the upper portion of the lower limbs to induce muscle adaptations and~improve metabolic health outcomes. The innovative protocol is designed to probe the potential benefits of BFRw in ameliorating insulin sensitivity and enhancing aerobic capacity, thus presenting a pioneering exercise approach for individuals with Type 2 Diabetes.
Study NCT06290947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Walking Training Program
Description: The control group will engage in a standard walking training regimen, consisting of supervised treadmill sessions without the application of BFR cuffs. This protocol serves to uphold the scientific rigor of the study by offering a comparison group for the BFRw intervention.~Purpose:~To evaluate the impact of a typical exercise routine on insulin sensitivity and aerobic capacity, thereby establishing a control benchmark to contrast with the effects of the BFRw intervention.